American Type Culture Collection, Inc. /
Lifeline Cell Technology, LLC
American Type Culture Collection, Inc. completed its deal for Lifeline Cell Technology, LLC.
Source for the buyer and target: International Stem Cell Corporation
For the buyer and target.
“On September 1, 2026, International Stem Cell Corporation (the “Company”) completed the sale of 100% of the membership interests of its wholly-owned subsidiary, Lifeline Cell Technology, LLC (“LCT”), to American Type Culture Collection, Inc. (“ATCC”) pursuant to the Membership Interest Purchase Agreement (the “MIPA”) dated July 10, 2026, for an adjusted purchase price of $25,250,000 (base purchase price of $25,000,000 plus a fixed cash add-back of $250,000), subject to a post-closing working capital true-up.”
Published 8 Sep 2026
Open the sourceWhat happened
The deal for Lifeline Cell Technology, LLC has closed, with American Type Culture Collection, Inc. as the buyer, at a stated price of $25,250,000. [01]
The filing from International Stem Cell Corporation is dated Sept. 8, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
American Type Culture Collection, Inc. completed its deal for Lifeline Cell Technology, LLC.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“The filing from International Stem Cell Corporation is dated Sept. 8, 2026”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly